LAURA E RYAN

Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism COLUMBUS, OH NPI 1619984416

General Payments — all program years on this page

$103,175.71

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 83
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $9,900.70 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $8,794.7012
Ascendis Pharma Inc $1,106.001

By program year

Program yearAmountRecords
2018 $14,497.1112
2019 $29,946.6324
2020 $7,788.006
2021 $19,778.9014
2022 $4,200.002
2023 $17,064.3712
2024 $9,900.7013

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1111694204 Amgen Inc. $23.00 03/26/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1111694206 Amgen Inc. $2,400.00 03/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1111694208 Amgen Inc. $1,600.00 03/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1111694210 Amgen Inc. $6.79 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111694212 Amgen Inc. $66.90 03/26/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1111694214 Amgen Inc. $466.20 01/30/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1111694216 Amgen Inc. $303.24 03/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1111694218 Amgen Inc. $2,400.00 06/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1111694220 Amgen Inc. $200.00 02/16/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1111694222 Amgen Inc. $600.00 03/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1111694224 Amgen Inc. $600.00 12/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1111694226 Amgen Inc. $128.57 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133851071 Ascendis Pharma Inc $1,106.00 12/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.